The expression levels of the checkpoint inhibitory molecule PD-1, the cell activation marker CTLA-4, the cytotoxic molecule granzyme B, and the cell proliferation marker Ki-67 by tumor infiltrating and splenic CD8+ and CD4+ T cells were not different between the groups (Supplementary Figures 1C–F). The gene discussed is PDCD1; the disease is neoplasm.